The role of T-helper 17 (Th17) cells in patients with medulloblastoma

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 611-619

  Zhou, P ^a   Sha, H ^a,b   Zhu, J ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Interleukin 17; Interleukin 23; Medulloblastoma; Retinoid orphan nuclear receptor; T helper 17 (Th17) cells

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 26; MESSENGER RNA; ORPHAN NUCLEAR RECEPTOR; RETINOID ORPHAN NUCLEAR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MEDULLOBLASTOMA; NEUROMODULATION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TH17 CELL;

EID: 77953702039     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800223     Document Type: Article

References (29)

1. Rossi A, Caracciolo V, Russo G, et al: Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res 2008; 14: 971-976.
2. Crawford JR, MacDonald TJ, Packer RJ: Medulloblastoma in childhood: new biological advances. Lancet Neurol 2007; 6: 1073-1085.
3. Zeltzer PM, Boyett JM, Finlay JL, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999; 17: 832-845.
4. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
5. H17 and regulatory T cells. Nature 2006; 441: 235-238.
6. H17 lineage. Nature 2006; 441: 231-234.
7. Dong C: Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 2006; 6: 329-333.
8. Ouyang W, Rolls JK, Zheng Y: The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-467.
9. H17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337-348.
10. + T helper cells. Cell 2006; 126: 1121-1133.
11. McGeachy MJ, Cua DJ: Th17 cell differentiation: the long and winding road. Immunity 2008; 28: 445-453.
12. Yang L, Anderson DE, Baecher-Allan C, et al:. IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature 2008; 454: 350-352.
13. H-17 responses. Nat Immunol 2008; 9: 650-657.
14. H-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat Immunol 2008; 9: 641-649.
15. Kato T, Furumoto H, Ogura T, et al: Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun 2001; 282: 735-738.
16. Steiner GE, Newman ME, Paikl D, et al:. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 2003; 56: 171-182.
17. Cirée A, Michel L, Camilleri-Bröet S, et al:. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Int J Cancer 2004; 112: 113-120.
18. Langowski JL, Zhang X, Wu L, et al:. IL-23 promotes tumour incidence and growth. Nature 2006; 442: 461-465.
19. Le Gouvello S, Bastuji-Garin S, Aloulou N, et al:. High prevalence of Foxp3 and IL17 in MMR-proflcient colorectal carcinomas. Cut 2008; 57: 772-779.
20. Kryczek I, Wei S, Zou L, et al:. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 2007; 178: 6730-6733.
21. Muranski P, Boni A, Antony PA, et al:. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008; 112: 362-373.
22. Langowski JL, Kastelein RA, Oft M: Swords into plowshares: IL-23 repurposes tumor immune surveillance. Trends Immunol 2007; 28: 207-212.
23. reg skewing. Clin Cancer Res 2008; 14: 3254-3261
24. Willis SN, Mallozzi SS, Rodig SJ, et al:. The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response. J Immunol 2009; 182: 3310-3317.
25. Raffaghello L, Nozza P, Morandi F, et al:. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. Cancer Res 2007; 67: 5471-5478.
26. Numasaki M, Fukushi J, Ono M, et al:. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101: 2620-2627.
27. Numasaki M, Watanabe M, Suzuki T, et al: IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005; 175:6177-6189.
28. Ahmed N, Ratnayake M, Savoldo B, et al: Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res 2007; 67: 5957-5964.
29. Wang J, Pham-Mitchell N, Schindler C, et al: Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-α-stimulated STAT2-independent production of IFN-γ in the brain. J Clin Invest 2003; 112: 535-543.